Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer
3
×
life sciences
national
3
×
national blog main
national top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
colorectal cancer
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
new york blog main
new york top stories
pfizer
roche
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
actavalon
acute myeloid leukemia
aileron therapeutics
amgen
aprea therapeutics
arena pharmaceuticals
What
cancer
3
×
annual
ash
barcelona
blood
broader
clinical
company
conference
december's
detect
developing
drug
eisai
esmo
european
fda
files
firms
flags
grail
higher
incidence
intended
investors
ipo
join
kras
life
lorcaserin
loss
major
market
marketing
medical
medicine
meeting
oncology
parp
patients
Language
unset
3
×
Current search:
unset
×
cancer
×
national
×
cancer
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More